In the pan-cancer cohort, comprising 505 tumors the promoter regions with the most significant FM bias comprise a shortlist of interesting candidate drivers, such as those of TERT (details in Fig. 3b), SYF2, ARGHEF18, and POLR2D. Here, TERT is linked to cancer.